A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfw408 ◽

2017 ◽

pp. gfw408 ◽

Cited By ~ 8

Author(s):

Masafumi Fukagawa ◽

Keitaro Yokoyama ◽

Takashi Shigematsu ◽

Takashi Akiba ◽

Akifumi Fujii ◽

...

Keyword(s):

Secondary Hyperparathyroidism ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Amg 416

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30426-0 ◽

2019 ◽

Vol 7 (3) ◽

pp. 249-259 ◽

Cited By ~ 43

Author(s):

Florian von Groote-Bidlingmaier ◽

Ramonde Patientia ◽

Epifanio Sanchez ◽

Vincent Balanag ◽

Eduardo Ticona ◽

...

Keyword(s):

Multidrug Resistant ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Background Regimen ◽

Parallel Group

Download Full-text

A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort

International Journal of Colorectal Disease ◽

10.1007/s00384-019-03416-w ◽

2019 ◽

Vol 34 (11) ◽

pp. 1971-1978

Author(s):

Raunak Jay Soman ◽

Malisetty Venkat Swamy

Keyword(s):

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Gastrointestinal Discomfort

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Cited By ~ 17

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD

10.1183/1393003.congress-2017.pa1812 ◽

2017 ◽

Author(s):

Gary Ferguson ◽

Krishna K. Pudi ◽

Gregory Feldmann ◽

Srikanth Pendyala ◽

Chris N. Barnes ◽

...

Keyword(s):

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Muscarinic Antagonist ◽

Double Blind Placebo ◽

Parallel Group ◽

Long Acting ◽

Severe Copd

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

Journal of Clinical Hypertension ◽

10.1111/j.1524-6175.2007.06679.x ◽

2007 ◽

Vol 9 (9) ◽

pp. 667-676 ◽

Cited By ~ 39

Author(s):

Robert J. Weiss ◽

Michael A. Weber ◽

Albert A. Carr ◽

Will A. Sullivan

Keyword(s):

Moderate Hypertension ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Β Blocker

Download Full-text

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study

Sleep Medicine ◽

10.1016/j.sleep.2013.07.007 ◽

2013 ◽

Vol 14 (11) ◽

pp. 1085-1091 ◽

Cited By ~ 13

Author(s):

Yuichi Inoue ◽

Tetsuo Shimizu ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Jun Ishigooka ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Restless Legs ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Advances in Therapy ◽

10.1007/s12325-018-0702-4 ◽

2018 ◽

Vol 35 (5) ◽

pp. 737-748 ◽

Cited By ~ 38

Author(s):

William W. Busse ◽

Jorge F. Maspero ◽

Klaus F. Rabe ◽

Alberto Papi ◽

Sally E. Wenzel ◽

...

Keyword(s):

Severe Asthma ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995301.793474894 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Kamran Sajadi

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Parallel Group

Download Full-text